Liu Qiang, Chairman of YaoPharma, said: "By leveraging Pfizer's exceptional global development experience and commercialisation network, along with YaoPharma's profound expertise in small molecule R&D and manufacturing, our shared goal is to accelerate the global development and commercialisation of this innovative drug, thereby benefiting patients worldwide more rapidly and extensively." Pfizers moves with Metsera and now YaoPharma add to continued competition in the obesity drug market, which has also seen Teva Pharmaceuticals gain US Food and Drug Administration (FDA) approval in August of a generic GLP-1 of its version of Novo Nordisks injectable Saxenda (liraglutide).
RCC201807), the Jiangsu Province Key Experiments of Basic and Clinical Translation of Non-coding RNA (grant no
Our comprehensive guide will clarify BCBCs coverage for Zepbound including the new prior authorization criteria and alternative options in case you cant obtain insurance coverage
It could, for example, take anywhere between 4 weeks to 6 months (in more complex cases)
Compounded Injectable GLP-1s Hers may offer access to compounded GLP-1 prescriptions in some cases, depending on clinician determination, state availability, and current program offerings
